Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miri Kim

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Dermatology|April 28, 2025
Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance StudyBong Seok Shin, Miri Kim, Moo Kyu Suh, et al.
Journal of Clinical Medicine|January 28, 2026
Factors Predicting Guselkumab Treatment Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of Korean Real-World DataYoung Bok Lee, Bong Seok Shin, Miri Kim, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
The Journal of Clinical Investigation|October 10, 2023
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blistersDawoon Han, A Yeong Lee, Taehee Kim, et al.
Research Square|October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Dermatology|April 28, 2025
Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance StudyBong Seok Shin, Miri Kim, Moo Kyu Suh, et al.
Journal of Clinical Medicine|January 28, 2026
Factors Predicting Guselkumab Treatment Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of Korean Real-World DataYoung Bok Lee, Bong Seok Shin, Miri Kim, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.
The Journal of Clinical Investigation|October 10, 2023
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blistersDawoon Han, A Yeong Lee, Taehee Kim, et al.
Research Square|October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
Pageof 18